Issue : 21 January 2008
View all stories from this issue.
Walk-in centres on the way for WalesSubscription
Plans to open Wales’ first nurse led walk-in centre may have moved a step closer.
Nurse donates kidney to patientSubscription
A Devon nurse has donated one of her kidneys to help save the life of a patient.
A three-minute interview with Ray Poll, nurse consultant in viral hepatitis at Sheffield Teaching Hospitals NHS Foundation Trust on the government’s FaCeIt hepatitis C awareness campaign.
What did the media say?
Patients with COPD achieve longer exercise duration with exercise training and ventilation training, a study has found.
Nurses urged to look after themselves betterSubscription
A campaign to help nurses look after their own health has been launched by the Queen’s Nursing Institute.
Targeted drug for colorectal cancerSubscription
A new targeted treatment for advanced colorectal cancer has been launched in theUK. Panitumumab (Vectibix) is the ...
NHS patients in Wales should have access to a new treatment for chronic myeloid leukaemia (CML), according to the All Wales Medicines Strategy Group.Dasatinib (Sprycel) has been recommended for the treatment of adults with chronic or accelerated phase CML, where there is resistance or intolerance to prior therapy including imatinib mesylate. The drug is an oral tyrosine kinase inhibitor that blocks leukaemia cell growth, enabling adults with certain types of the CML ...
Novel plaster that delivers pain reliefSubscription
A novel plaster that delivers anaesthetics, the first of its kind, has been launched in the UK.Raydan combines an innovative gentle warming system with two potent anaesthetics, lidocaine and tetracaine, to provide pain management.Its manufacturer, EUSA Pharma, said the system worked twice as fast as topical cream and eliminated pain in 95% of patients after half an hour.The company claim it will help prevent needle phobia in children and free up nursing time.
New add-on therapy for kidney cancerSubscription
An add-on therapy for treating kidney cancer patients has been launched in the UK.